MPM Capital Biotechnology Retreat 2010 – Health Care M&A and Partnering Forum 

  • 5.1.2010 | -

David Redlick



Not sure where to start?

Let our Knowledge Navigator direct you to content specific to where you are on your journey.

Get Started!
Rss Feed
7.4.2026
How America's 250th birthday became a test of AI-powered collective intelligence 
7.4.2026
Trunk Tools' stack cut document review from 60 days to 10 by ditching general-purpose models 
7.2.2026
Enterprises lost Claude Fable 5 for a few weeks. New data shows two-thirds had already built their hedge 
Featured
blog-launch-550x370

This blog post explains why a Section 409A valuation is essential for private companies issuing equity compensation.

4.13.2026
Don’t Let Australia’s R&D Tax Incentive Trigger Unintended US International Tax Cost Sharing Issues
10.13.2025
Back to Basics: Why Get a Section 409A Valuation?
10.6.2025
Back to Basics: How to Grant a Stock Option